Interestingly, genetic studies revealed that the PD1.3 polymorphism has been linked to increased SLE susceptibility, whereas PD1.6 is associated with decreased risk, indicating the contribution of PD-1 variants to loss of TRM regulation and lupus myocarditis pathogenesis102,103. This evidence concerns the gene PDCD1 and systemic lupus erythematosus.